Abstract
In order to develop an anti-FMDV A Type monoclonal antibody (mAb), BABL/c mice were immunized with FMDV A type. Monoclonal antibodies (mAbs) 7B11 and 8H4 against Foot-and-mouth disease virus (FMDV) serotype A were produced by fusing SP2/0 myeloma cells with splenocyte from the mouse immunized with A/AV88. The microneutralization titer of the mAbs 7B11 and 8H4 were 1024 and 512, respectively. Both mAbs contain kappa light chains, the mAbs were IgG1. In order to define the mAbs binding epitopes, the reactivity of these mAbs against A Type FMDV, were examined using indirect ELISA, the result showed that both mAbs reacted with A Type FMDV. These mAbs may be used for further vaccine studies, diagnostic methods, prophylaxis, etiological and immunological research on FMDV. Characterization of these ncindicated that prepared anti-FMDV A mAbs had no cross-reactivity with Swine Vesicular Disease (SVD) or FMDV O, Asia1 and C Type antigens. Their titers in abdomen liquor were 1:5×106 and 1:2×106, respectively. 7B11 was found to be of subtype IgG1, 8H4 was classified as IgG2b subtype. The mAbs prepared in this study, are specific for detection of FMDV serotype A, and is potentially useful for pen-side diagnosis.
Key words: Foot-and-mouth disease virus (FMDV) A Type, Monoclonal antibody (mAb), Neutralizing activity
Footnotes
Foundation items: State Key Projects of Transgene Program (2011ZX08011-004; 2009ZX 08007-008B; 2009ZX08006-002B)
References
- 1.Barteling S. J. Modern inactivated foot-and mouth disease vaccines: historical background and key elements in production and use. In: Sobrino F., Domingo E., editors. Foot-and-Mouth Disease: Current Perspectives. England: Horizon Bioscience; 2004. pp. 305–333. [Google Scholar]
- 2.Du J. Z., Chang H. Y., Cong G. Z., et al. Molecular characteristics and expression of structural protein gene of Foot-and-Mouth Disease virus type Asia1. Virol Sin. 2005;20(1):65–69. [Google Scholar]
- 3.Freiberg B, Hohlich B, Haas B, et al. Type-independent detection of foot-and-mouth disease virus by monoclonal antibodies that bind to amino-terminal residues of capsid protein VP2. J Virol Methods, 92: 199–205. [DOI] [PubMed]
- 4.Feldmann M., Maini R. N. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Annu Rev Immunol. 2001;19:163–96. doi: 10.1146/annurev.immunol.19.1.163. [DOI] [PubMed] [Google Scholar]
- 5.Guo H., Liu Z., Sun S., et al. Immune response in guinea pigs vaccinated with DNA vaccine of foot-and-mouth disease virus O/China99. Vaccine. 2005;23:3236–3242. doi: 10.1016/j.vaccine.2004.03.074. [DOI] [PubMed] [Google Scholar]
- 6.Golding S. M., Hedger R. S. Radial immunodiffusion and serum neutralization techniques for the assay of antibodies to swine vesicular disease. Res Vet Sci. 1976;20:142–147. [PubMed] [Google Scholar]
- 7.Jackson T., King A. M., Stuart D. I., et al. Structure and receptor binding. Virus Res. 2003;91:33–46. doi: 10.1016/S0168-1702(02)00258-7. [DOI] [PubMed] [Google Scholar]
- 8.Klein J., Hussain M., Ahmad M., et al. Genetic characterisation of the recent foot-and-mouth disease virus subtype A/IRN/2005. Virol J. 2007;4:122. doi: 10.1186/1743-422X-4-122. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Kovacs-Nolan J., Sasaki E., Yoo D., et al. Cloning and expression of human rotavirus spike protein, VP8*, in Escherichia coli. Biochem Biophys Res Commun. 2001;282:1183–1188. doi: 10.1006/bbrc.2001.4717. [DOI] [PubMed] [Google Scholar]
- 10.Lin T., Du J. Z., Shao J. J., et al. Application of VP1 Protein to Develop Monoclonal Antibody against Foot-and-mouth Disease Virus Asia1 Type. Virol Sin. 2009;24(3):215–220. doi: 10.1007/s12250-009-2986-z. [DOI] [Google Scholar]
- 11.Lundberg M., Holmgren A., Johansson M. Human glutaredoxin 2 affinity tag for recombinant peptide and protein purification. Protein Expr Purif. 2006;45:37–42. doi: 10.1016/j.pep.2005.07.001. [DOI] [PubMed] [Google Scholar]
- 12.Smith D. B. Generating fusions to glutathione S-transferase for protein studies. Methods Enzymol. 2000;326:254–270. doi: 10.1016/S0076-6879(00)26059-X. [DOI] [PubMed] [Google Scholar]